Cargando…

Defective viral genomes can protect against SARS-CoV-2 variants and other respiratory viruses

Detalles Bibliográficos
Autor principal:	Flemming, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641288/ https://www.ncbi.nlm.nih.gov/pubmed/34862485 http://dx.doi.org/10.1038/s41577-021-00668-y

Ejemplares similares

Cross-viral protection against SARS-CoV-2?
por: Reed, Sophie G.
Publicado: (2020)

SARS-CoV-2 variant evades antibodies whilst maintaining fitness
por: Flemming, Alexandra
Publicado: (2021)

SARS-CoV-2 Delta variant excels at membrane fusion, but not immune evasion
por: Flemming, Alexandra
Publicado: (2021)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

Cross-reactive tissue-resident CD8(+) T cells may provide first line of defence against SARS-CoV-2
por: Flemming, Alexandra
Publicado: (2021)

Vaccines only partially protect against Long COVID
por: Flemming, Alexandra
Publicado: (2022)

Cross-reactive memory T cells abort SARS-CoV-2 infection
por: Flemming, Alexandra
Publicado: (2021)

Intracranial inflammatory mediators involved in SARS-CoV-2 neurological manifestations?
por: Flemming, Alexandra
Publicado: (2021)

Foetal sex affects maternal and placental immune responses to SARS-CoV-2
por: Flemming, Alexandra
Publicado: (2021)

‘Prime and spike’ induces mucosal immunity and reduces SARS-CoV-2 transmission
por: Flemming, Alexandra
Publicado: (2022)

Comparing neurological complications after COVID-19 vaccination and SARS-CoV-2 infection
por: Flemming, Alexandra
Publicado: (2021)

Coinfections with SARS-CoV-2 and other respiratory pathogens
por: Hazra, Aniruddha, et al.
Publicado: (2020)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

Diabetes enhances viral loads in COVID-19
por: Flemming, Alexandra
Publicado: (2022)

Are variant-specific vaccines warranted?
por: Flemming, Alexandra
Publicado: (2022)

Epitope mapping of spike identifies variant-resistant antibodies
por: Flemming, Alexandra
Publicado: (2021)

A defective viral genome strategy elicits broad protective immunity against respiratory viruses
por: Xiao, Yinghong, et al.
Publicado: (2021)

Deciphering the protective features of the antibody response
por: Flemming, Alexandra
Publicado: (2021)

Poor nasal immunity can lead to severe COVID-19
por: Flemming, Alexandra
Publicado: (2021)

Omicron alone provides limited cross-protection
por: Flemming, Alexandra
Publicado: (2022)

Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses
por: Jacot, Damien, et al.
Publicado: (2020)

Monovalent vaccination with inactivated SARS-CoV-2 BA.5 protects hamsters against Omicron but not non-Omicron variants
por: Ong, Chon Phin, et al.
Publicado: (2023)

Cross reactive T cells hold up against Omicron
por: Flemming, Alexandra
Publicado: (2022)

Comparative Performance Evaluation of Personal Protective Measures and Antiviral Agents Against SARS-CoV-2 Variants: A Narrative Review
por: Haque, Md Anamul, et al.
Publicado: (2023)

Clinical Features and Duration of Viral Shedding in Individuals With SARS-CoV-2 Omicron Variant Infection
por: Jang, Young R, et al.
Publicado: (2022)

Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients
por: Plante, Jessica A., et al.
Publicado: (2022)

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants
por: Zhang, Jason Z., et al.
Publicado: (2022)

Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness
por: Falsey, Ann R., et al.
Publicado: (2014)

Human antibodies can neutralize SARS-CoV-2
por: Catalan-Dibene, Jovani
Publicado: (2020)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
por: Bian, Lianlian, et al.
Publicado: (2022)

Can T Cells Abort SARS-CoV-2 and Other Viral Infections?
por: Swadling, Leo, et al.
Publicado: (2023)

Stability of SARS-CoV-2 and other airborne viruses under different stress conditions
por: Fumagalli, Marcilio Jorge, et al.
Publicado: (2021)

Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
por: Granerud, Beathe K., et al.
Publicado: (2022)

The rising of old foes: impact of lockdown periods on “non-SARS-CoV-2” viral respiratory and gastrointestinal infections
por: Maison, Nicole, et al.
Publicado: (2022)

Exploring Viral Metagenomics in Pediatric Patients with Acute Respiratory Infections: Unveiling Pathogens beyond SARS-CoV-2
por: de Campos, Gabriel Montenegro, et al.
Publicado: (2023)

Massively multiplexed affinity characterization of therapeutic antibodies against SARS-CoV-2 variants
por: Engelhart, Emily, et al.
Publicado: (2022)

Serum Neutralization Against SARS-CoV-2 Variants Is Heterogenic and Depends on Vaccination Regimen
por: Jäger, Michael, et al.
Publicado: (2022)

Vaccination against SARS-CoV-2 Does Not Protect against the Development of Anosmia in a Hamster Model
por: Reyna, Rachel A., et al.
Publicado: (2023)

Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant
por: Acharya, Charlotte B, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_os1tuut416rh6r6sn3osv0qef1